Second Sight Medical Products Inc (NASDAQ:EYES)
| 4.81 Delayed Data As of 4:00pm ET |  +0.48 / +11.09%Today’s Change | 3.56 Today|||52-Week Range 9.60 | -18.97% Year-to-Date |
Latest EYES News | Press Releases
No recent news for Second Sight Medical Products Inc.
Today’s Trading
| Previous close | 4.33 |
| Today’s open | 4.40 |
| Day’s range | 4.34 - 4.83 |
| Volume | 60,651 |
| Average volume (3 months) | 35,962 |
| Market cap | $67.4M |
Data as of 4:00pm ET, 01/28/2020
Growth & Valuation
| Earnings growth (last year) | +0.25% |
| Earnings growth (this year) | +40.22% |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | -13.41% |
| P/E ratio | NM |
| Price/Sales | 8.52 |
| Price/Book | 13.40 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| APENApollo Endosurgery I... | +0.04 | +1.33% |
| CFMSConformis Inc | -0.03 | -2.78% |
| ENLVEnlivex Therapeutics... | +0.47 | +5.52% |
| CLGNCollplant Biotechnol... | +0.73 | +7.09% |
Data as of 4:00pm ET, 01/28/2020
Financials
| Next reporting date | March 5, 2020 |
| EPS forecast (this quarter) | -$0.48 |
| Annual revenue (last year) | $6.9M |
| Annual profit (last year) | -$35.1M |
| Net profit margin | -508.90% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Sylmar, California |
Forecasts
